Clinical Trial Update: An Ascending Dose Comparison of MVT-100 to Definity in Healthy Volunteers [Phase 1, Phase 2]

View source ↗

Summary

The trial update reports a completed ascending-dose Phase 1/2 comparison of MVT-100 to Definity in healthy volunteers to evaluate safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Diseases

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)
• MVT-100

Snippet

Sponsor: Microvascular Therapeutics, LLC | Conditions: Heart Diseases | Phase 1, Phase 2 | Status: COMPLETED